Elizabeth Cooney

4.3k total citations · 1 hit paper
61 papers, 2.8k citations indexed

About

Elizabeth Cooney is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Hepatology. According to data from OpenAlex, Elizabeth Cooney has authored 61 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 14 papers in Public Health, Environmental and Occupational Health and 12 papers in Hepatology. Recurrent topics in Elizabeth Cooney's work include Palliative Care and End-of-Life Issues (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (8 papers). Elizabeth Cooney is often cited by papers focused on Palliative Care and End-of-Life Issues (12 papers), Hepatitis C virus research (11 papers) and Hepatitis B Virus Studies (8 papers). Elizabeth Cooney collaborates with scholars based in United States, Canada and Germany. Elizabeth Cooney's co-authors include Scott D. Halpern, Nicole B. Gabler, Saida Kent, Michael O. Harhay, Kuldeep N. Yadav, Katherine R. Courtright, Nicole Herbst, Jennifer Kim, Frederick L. Altice and Gerald Friedland and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Elizabeth Cooney

60 papers receiving 2.7k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Approximately One In Three US Adults Completes Any Type Of Advance Directive For End-Of-Life Care

2017 386 citations Nicole B. Gabler, Elizabeth Cooney et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elizabeth Cooney United States	28	970	760	456	456	355	61	2.8k
Sascha Ellington United States	28	860 0.9×	1.4k 1.8×	254 0.6×	1.6k 3.5×	373 1.1×	124	4.6k
Doug Campos‐Outcalt United States	30	940 1.0×	790 1.0×	315 0.7×	835 1.8×	673 1.9×	147	3.8k
Geraldo Duarte Brazil	30	1.0k 1.1×	954 1.3×	166 0.4×	781 1.7×	332 0.9×	277	3.5k
David Goldberg United States	44	5.0k 5.1×	538 0.7×	334 0.7×	1.1k 2.3×	455 1.3×	240	7.2k
Joseph Feldman United States	44	1.8k 1.9×	696 0.9×	471 1.0×	1.3k 2.9×	796 2.2×	132	6.5k
James Korelitz United States	21	1.3k 1.3×	175 0.2×	403 0.9×	722 1.6×	174 0.5×	41	3.0k
Jack DeHovitz United States	33	1.8k 1.9×	216 0.3×	569 1.2×	2.5k 5.4×	497 1.4×	151	4.0k
Tonya M. Esterhuizen South Africa	25	640 0.7×	481 0.6×	159 0.3×	698 1.5×	583 1.6×	156	2.4k
Howard Minkoff United States	29	1.3k 1.4×	407 0.5×	339 0.7×	835 1.8×	295 0.8×	84	2.8k
Raúl Andrés Mendoza-Sassi Brazil	26	807 0.8×	382 0.5×	110 0.2×	321 0.7×	700 2.0×	104	2.3k

Countries citing papers authored by Elizabeth Cooney

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Cooney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Cooney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Cooney more than expected).

Fields of papers citing papers by Elizabeth Cooney

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Cooney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Cooney. The network helps show where Elizabeth Cooney may publish in the future.

Co-authorship network of co-authors of Elizabeth Cooney

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Cooney. A scholar is included among the top collaborators of Elizabeth Cooney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Cooney. Elizabeth Cooney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Halpern, Scott D., Brian Bayes, Elizabeth Cooney, et al.. (2021). Effectiveness and Ethics of Incentives for Research Participation. JAMA Internal Medicine. 181(11). 1479–1479. 29 indexed citations

Lim, Joseph K., Atif Zaman, Paul Martin, et al.. (2020). Clinical Outcome Event Adjudication in a 10-Year Prospective Study of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 8(4). 1–8. 4 indexed citations

Detsky, Michael E., Michael O. Harhay, Aaron M. Delman, et al.. (2017). Six-Month Morbidity and Mortality among Intensive Care Unit Patients Receiving Life-Sustaining Therapy. A Prospective Cohort Study. Annals of the American Thoracic Society. 14(10). 1562–1570. 30 indexed citations

Gabler, Nicole B., Elizabeth Cooney, Dylan S. Small, et al.. (2016). Default options in advance directives: study protocol for a randomised clinical trial. BMJ Open. 6(6). e010628–e010628. 7 indexed citations

Auriemma, Catherine L., Lucy Chen, Aaron M. Delman, et al.. (2016). Public Opinion Regarding Financial Incentives to Engage in Advance Care Planning and Complete Advance Directives. American Journal of Hospice and Palliative Medicine®. 34(8). 721–728. 7 indexed citations

Courtright, Katherine R., Vanessa Madden, Nicole B. Gabler, et al.. (2016). Rationale and Design of the Randomized Evaluation of Default Access to Palliative Services (REDAPS) Trial. Annals of the American Thoracic Society. 13(9). 1629–1639. 21 indexed citations

Santagostino, Elena, Stanislas Pol, Antonio Olveira, et al.. (2016). Daclatasvir/peginterferon lambda‐1a/ribavirin in patients with chronic HCV infection and haemophilia who are treatment naïve or prior relapsers to peginterferon alfa‐2a/ribavirin. Haemophilia. 22(5). 692–699. 7 indexed citations

Auriemma, Catherine L., et al.. (2015). An Observational Study of Decision Making by Medical Intensivists. Critical Care Medicine. 43(8). 1660–1668. 48 indexed citations

Chan, Henry Lik‐Yuen, Sang Hoon Ahn, Ting‐Tsung Chang, et al.. (2015). Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B). Journal of Hepatology. 64(5). 1011–1019. 80 indexed citations

10.

Myler, Heather, Matthew Hruska, Subasree Srinivasan, et al.. (2015). Anti-Peg Antibody Bioanalysis: A Clinical Case Study with Peg-Ifn-λ-1A and Peg-Ifn-α2A in Naive Patients. Bioanalysis. 7(9). 1093–1106. 28 indexed citations

11.

Harhay, Michael O., Jason Wagner, Sarah J. Ratcliffe, et al.. (2014). Outcomes and Statistical Power in Adult Critical Care Randomized Trials. American Journal of Respiratory and Critical Care Medicine. 189(12). 1469–1478. 125 indexed citations

12.

Kerlin, Meeta Prasad, Michael O. Harhay, Kelly C. Vranas, et al.. (2014). Objective Factors Associated with Physicians’ and Nurses’ Perceptions of Intensive Care Unit Capacity Strain. Annals of the American Thoracic Society. 11(2). 167–172. 27 indexed citations

13.

Kerlin, Meeta Prasad, Dylan S. Small, Elizabeth Cooney, et al.. (2013). A Randomized Trial of Nighttime Physician Staffing in an Intensive Care Unit. New England Journal of Medicine. 368(23). 2201–2209. 115 indexed citations

14.

Tatum, H., Paul J. Thuluvath, E. Läwitz, et al.. (2012). 1163 A PHASE 2A STUDY OF BMS-791325, AN NS5B POLYMERASE INHIBITOR, WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS WITH GENOTYPE 1 CHRONIC HEPATITIS C INFECTION. Journal of Hepatology. 56. S460–S460. 4 indexed citations

15.

Lederman, Michael M., Ray A. McKinnis, Dennis Kelleher, et al.. (2000). Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase. AIDS. 14(17). 2635–2642. 69 indexed citations

16.

Nagy-Agren, Stephanie & Elizabeth Cooney. (1999). Interleukin‐12 Enhancement of Antigen‐Specific Lymphocyte Proliferation Correlates with Stage of Human Immunodeficiency Virus Infection. The Journal of Infectious Diseases. 179(2). 493–496. 11 indexed citations

17.

Lee, Michael S., Elizabeth Cooney, Kathleen Stoessel, & Ray F. Gariano. (1998). Varicella zoster virus retrobulbar optic neuritis preceding retinitis in patients with acquired immune deficiency syndrome. Ophthalmology. 105(3). 467–471. 22 indexed citations

18.

Aronin, Steven I., et al.. (1998). Review of Pneumococcal Endocarditis in Adults in the Penicillin Era. Clinical Infectious Diseases. 26(1). 165–171. 121 indexed citations

19.

Cooney, Elizabeth, M J McElrath, Lawrence Corey, et al.. (1993). Enhanced immunity to human immunodeficiency virus (HIV) envelope elicited by a combined vaccine regimen consisting of priming with a vaccinia recombinant expressing HIV envelope and boosting with gp160 protein.. Proceedings of the National Academy of Sciences. 90(5). 1882–1886. 148 indexed citations

20.

Cooney, Elizabeth. (1991). Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein. The Lancet. 337(8741). 567–572. 273 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact